End points
above-knee, major amputation, death, bleeding, restenosis
ADVERSE EVENTS, BLEEDING, RESTENOSIS
The primary endpoint was the binary restenosis rate, defined as > 50% luminal reduction of the initially treated FP lesion on CTA or catheter angiography at six months post-intervention. Secondary endpoints were target lesion revascularization, major amputation (unplanned ipsilateral below-knee or above-knee amputation), major bleeding (bleeding requiring ≥ 2 units of blood transfusion, surgical intervention, or inotropic support), death from any cause, and serious adverse events during the study period